Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression.

The difference in survival between the two groups was highly significant ( p ≤ 0.001, log-rank Mantel–Cox test) for both U251 ( Figure 6 d) and U87 ( Figure 6 e) models.

also in 132,142 other papers